The United States represents the largest share of the North American Nadolol Market, driven by the high prevalence of hypertension, angina, and other cardiovascular disorders. Growing healthcare expenditure, widespread access to prescription medications, and increasing awareness of preventive cardiac care continue to support market demand. Additionally, the presence of major...